The global liquid biopsy market has witnessed significant growth, attributing to the increasing demand for less invasive biopsies and other monitoring approaches while treating cancer patients. Liquid biopsies had also been instrumental in other settings including early screening, treatment decision, redesigning treatment approaches, and prenatal screening. Further, the increasing utilization of the non-invasive biopsy procedures in the developed and the developing countries is the key driver for the growth of the global liquid biopsy market.

The global infectious disease biomarker testing market is witnessing a significant flux with regard to the recent advancements that have already taken place and are currently invading the market space. Additionally, with the entry of large number of companies in the market and launch of new product lines, the market represents massive potential to grow at an unprecedented double-digit growth rate. Factors such as increasing prevalence of infectious diseases, rapidly growing aging population that is more susceptible to disease, rising healthcare awareness, and the increasing involvement of patients in personal healthcare are collectively driving the growth the global infectious disease biomarker testing market. Further, technological advancements improving the ability to analyze the increasing number of biomarkers coupled with the augmenting demand for biomarker tests to diagnose various types of infectious diseases are some of the prominent driving factors accelerating the growth of the market.

Immunoproteins are blood proteins with immunological activity, capable of affecting or changing the functioning of immune system. This property of immunoproteins serves as an indicator for diagnosing numerous infectious and chronic diseases, thereby increasing the demand for immunoprotein diagnostic tests carried out across laboratories and hospitals in the world. The immunoprotein diagnostic testing report provides market dynamics and global trends related to the immunoprotein diagnostic testing market. In addition, it presents the market estimations and forecast. The study estimates revenues that are confined to the sales of immunoprotein assays and kits used in diagnosis of diseases. However, the market estimates do not include revenue generated from the post-sale services of the assays & kits and doctor consultation fees.

Dialysis is a technique used to remove waste products such as urea and creatinine from blood, which occurs from inappropriate functioning of kidneys and is usually required for people suffering from chronic renal failure. This procedure is performed for treating kidney disorders and is classified into 2 types: hemodialysis and peritoneal dialysis. In hemodialysis, blood is pumped out of blood vessels and is purified with the help of dialyzer and then returned back to the body through vascular access. In peritoneal dialysis, the principle of the procedure remains same, however the inner lining of stomach called peritoneum is used as a filter to purify blood. This report includes the revenue generated from sales of all devices and consumables used for hemodialysis and peritoneal dialysis procedures. However, it excludes hemodialysis and peritoneal dialysis services revenue. The valuations comprise revenue generated from hemodialysis and peritoneal dialysis devices and consumables such as dialyzer, dialysis machine, catheter, and graft. Furthermore, the report excludes revenue generated from post-sale services of hemodialysis and peritoneal dialysis devices and consumables.

The global genetic counseling market has witnessed significant growth, attributing to the increasing demand for genetic counseling in both risk assessment and pharmacogenomics settings. In both settings, the findings identified through genetic counseling have been instrumental in improving the disease risk assessment, quality of life, and reducing the cost and time of the treatment. Further, the increasing awareness and adoption of the precision therapeutics and diagnostic approach in the developed and the developing countries is the key driver for the growth of the global genetic counseling market.

Market contribution of the products anticipated to be launched in the future has been calculated based on the historical analysis of the products. This analysis has been supported by proxy factors, such as innovation scale of the companies, status of funding, collaborations, and customer base. The scope of availability of a product in a particular region has been assessed based on comprehensive analysis of the companies’ future prospects, the regional end user perception, and other factors impacting the launch of a product in that region.

The healthcare payer solution can be defined as the services provided by the healthcare IT companies to payers, i.e. private and public insurers as well as insurance companies, to help with streamlining the business processes and reduce operational cost. The report provides market dynamics and trends related to the global healthcare payer solution market. In addition, it presents the market estimations and forecast. For the purpose of analysis, the global healthcare payer solution market is segmented into service, application, provider, and region. The study estimates revenue generated from the sale of services such as business process outsourcing services, information technology outsourcing services, and knowledge process outsourcing services. The applications covered in the study include pharmacy audit & analysis systems, claims management services, fraud management services, computer-assisted coding (CAC) systems, member eligibility management services, provider network management services, payment management services, customer relationship management services, medical document management services, and general ledger & payroll management. Moreover, the report covers revenue generated from the sales of healthcare payer solution offered in regions such as North America, Europe, Asia-Pacific, and LAMEA

The global hereditary genetic testing market is undergoing a significant flux with regard to the advancements that have already taken place and are currently invading the market space. Additionally, with the emergence genetic testing, there is immense potential for these emerging submarkets to continue to propel the overall hereditary genetic testing market. This chapter reviews the significant drivers and restraints that are considerably impacting the dynamicity of the global hereditary genetic testing market.

Herbal nutraceuticals are obtained from natural sources with no added chemicals or toxins. These products are highly effective, safer, and more tolerable as compared to conventional products available in the market. They help in maintaining health and act against nutritionally induced acute and chronic diseases, which promotes optimal health, longevity, and quality of life. Some common herbal nutraceuticals available in the market include aloe vera, ginger, garlic, green tea, and turmeric. The global herbal nutraceuticals market is analyzed on the basis of its prospects and future growth rate. The report highlights numerous factors that influence growth of the market. These include market forecast, drivers, restraints, opportunities, and role of different key players operating in the market. The report is analyzed for herbal nutraceuticals by product type including aloe vera, ginger, garlic, green tea, turmeric, and others. In addition, it focuses on the nature segment, which includes conventional and organics.

The nutrition and supplement industry has begun witnessing the real-life benefits of the eubiotics products in applications such as improving animals’ immune power, promoting efficient gut health, overall performance, nutrient uptake, and reducing the pathogenic and undesirable bacteria. Moreover, eubiotics products and ingredients have been amongst the most researched and developed products in the nutrition and supplement industry in the past five years. Popularly, the eubiotics products and ingredients in the industry are offered as probiotics, prebiotics, organic acids, and essential oils. This section of the study discusses all the eubiotics type offerings in the market in detail. Presently, the product and ingredient offerings in the market include probiotics, prebiotics, organic acids, and essential oils, as illustrated in the following figure.